Christoph MassnerinEarlybird's viewWill psychedelics revolutionize mental health treatment?5 ways psychedelics research and investment are evolvingJun 29, 2022Jun 29, 2022
Christoph MassnerinEarlybird's viewMiracor Medical is our second portfolio company to receive Breakthrough Device Designation from the…Earlybird is pleased to announce that Miracor Medical, based in Belgium, is our second portfolio company to receive Breakthrough Device…Aug 22, 2019Aug 22, 2019